Put Options

29 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.54 - $5.47 $148,326 - $229,193
-41,900 Reduced 39.27%
64,800 $257,000
Q2 2024

Aug 15, 2024

SELL
$3.04 - $4.23 $3,952 - $5,499
-1,300 Reduced 1.2%
106,700 $433,000
Q1 2024

May 07, 2024

BUY
$2.88 - $4.89 $257,472 - $437,166
89,400 Added 480.65%
108,000 $372,000
Q4 2023

Feb 14, 2024

SELL
$1.08 - $3.63 $69,120 - $232,320
-64,000 Reduced 77.48%
18,600 $60,000
Q3 2023

Nov 14, 2023

SELL
$2.81 - $5.69 $229,577 - $464,873
-81,700 Reduced 49.73%
82,600 $241,000
Q2 2023

Aug 11, 2023

BUY
$4.45 - $7.57 $222,945 - $379,257
50,100 Added 43.87%
164,300 $893,000
Q1 2023

May 16, 2023

BUY
$2.48 - $5.22 $122,760 - $258,390
49,500 Added 76.51%
114,200 $531,000
Q4 2022

Feb 14, 2023

SELL
$1.75 - $3.96 $227,150 - $514,008
-129,800 Reduced 66.74%
64,700 $146,000
Q3 2022

Nov 14, 2022

BUY
$3.09 - $7.46 $45,732 - $110,408
14,800 Added 8.24%
194,500 $613,000
Q2 2022

Aug 15, 2022

BUY
$1.92 - $6.28 $54,720 - $178,980
28,500 Added 18.85%
179,700 $494,000
Q1 2022

May 16, 2022

SELL
$5.07 - $7.2 $855,309 - $1.21 Million
-168,700 Reduced 52.74%
151,200 $909,000
Q4 2021

Feb 14, 2022

SELL
$5.67 - $8.54 $378,756 - $570,472
-66,800 Reduced 17.27%
319,900 $2.06 Million
Q3 2021

Nov 15, 2021

BUY
$13.4 - $16.3 $2.39 Million - $2.91 Million
178,700 Added 85.91%
386,700 $5.33 Million
Q2 2021

Aug 11, 2021

SELL
$14.81 - $19.13 $992,270 - $1.28 Million
-67,000 Reduced 24.36%
208,000 $3.09 Million
Q1 2021

May 17, 2021

SELL
$14.52 - $23.53 $1.09 Million - $1.77 Million
-75,400 Reduced 21.52%
275,000 $4.9 Million
Q4 2020

Feb 16, 2021

BUY
$10.14 - $15.19 $1.32 Million - $1.97 Million
129,800 Added 58.84%
350,400 $5.01 Million
Q3 2020

Nov 16, 2020

BUY
$9.57 - $21.32 $1.16 Million - $2.58 Million
120,900 Added 121.26%
220,600 $2.23 Million
Q2 2020

Aug 14, 2020

SELL
$12.21 - $16.99 $69,597 - $96,842
-5,700 Reduced 5.41%
99,700 $1.47 Million
Q1 2020

May 15, 2020

SELL
$9.03 - $19.72 $486,716 - $1.06 Million
-53,900 Reduced 33.84%
105,400 $1.41 Million
Q4 2019

Feb 14, 2020

SELL
$13.01 - $17.15 $65,050 - $85,750
-5,000 Reduced 3.04%
159,300 $2.25 Million
Q3 2019

Nov 14, 2019

BUY
$14.55 - $20.56 $768,240 - $1.09 Million
52,800 Added 47.35%
164,300 $2.68 Million
Q2 2019

Aug 14, 2019

SELL
$15.0 - $19.62 $189,000 - $247,212
-12,600 Reduced 10.15%
111,500 $1.75 Million
Q1 2019

May 15, 2019

SELL
$11.65 - $17.72 $121,160 - $184,288
-10,400 Reduced 7.73%
124,100 $2.16 Million
Q4 2018

Feb 14, 2019

SELL
$10.72 - $16.73 $347,328 - $542,052
-32,400 Reduced 19.41%
134,500 $1.5 Million
Q3 2018

Nov 14, 2018

SELL
$17.73 - $26.69 $2.7 Million - $4.07 Million
-152,500 Reduced 47.75%
166,900 $4.07 Million
Q2 2018

Aug 14, 2018

SELL
$10.79 - $24.44 $319,384 - $723,424
-29,600 Reduced 8.48%
319,400 $5.79 Million
Q1 2018

May 15, 2018

SELL
$9.0 - $20.16 $3.5 Million - $7.84 Million
-389,100 Reduced 52.72%
349,000 $3.9 Million
Q4 2017

Feb 14, 2018

SELL
$13.26 - $22.86 $3.39 Million - $5.84 Million
-255,600 Reduced 25.72%
738,100 $14.3 Million
Q3 2017

Nov 14, 2017

BUY
$19.76 - $24.9 $19.6 Million - $24.7 Million
993,700
993,700 $21.5 Million

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $423M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.